What is the FDA recommended regimen of urokinase for thrombolytic therapy of pulmonary embolism (PE)?

Updated: Aug 04, 2021
  • Author: Wanda L Rivera-Bou, MD, FAAEM, FACEP; Chief Editor: Erik D Schraga, MD  more...
  • Print


The FDA-approved urokinase regimen for PE consists of 4400 U/kg as a loading dose given at a rate of 90 mL/hr over a period of 10 minutes, followed by continuous infusion of 4400 U/kg/hr at a rate of 15 mL/hr for 12 hours.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!